Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZP150 for PTSD
NCT05178316Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JZP-150 in post-traumatic stress disorder (PTSD), sponsored by Jazz Pharmaceuticals plc. Started Dec 2021; status: completed.
02
Drugs
JZP-150
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05178316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05178316.